Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Dow
Cipla
Fuji
US Department of Justice
Cantor Fitzgerald
Colorcon
Chubb

Generated: July 18, 2018

DrugPatentWatch Database Preview

Amlodipine besylate; benazepril hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for amlodipine besylate; benazepril hydrochloride and what is the scope of amlodipine besylate; benazepril hydrochloride freedom to operate?

Amlodipine besylate; benazepril hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Lupin Pharms, Mylan, Par Pharm, Teva Pharms, Watson Labs, Watson Labs Inc, and Novartis, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty drug master file entries for amlodipine besylate; benazepril hydrochloride. Twenty-three suppliers are listed for this compound. There are two tentative approvals for this compound.
Pharmacology for amlodipine besylate; benazepril hydrochloride
Tentative approvals for AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial2.5MG; 10MGCAPSULE; ORAL
➤ Try a Free Trial➤ Try a Free Trial10MG; 20MGCAPSULE; ORAL
➤ Try a Free Trial➤ Try a Free Trial5MG; 20MGCAPSULE; ORAL

US Patents and Regulatory Information for amlodipine besylate; benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Pharms AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 078466-005 Jul 5, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 078381-001 Jul 29, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 078381-006 Jul 29, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 078381-004 Jul 29, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for amlodipine besylate; benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LOTREL amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 020364-004 Mar 3, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis LOTREL amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 020364-006 Apr 11, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis LOTREL amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 020364-003 Mar 3, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis LOTREL amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 020364-003 Mar 3, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Healthtrust
Argus Health
Teva
Cipla
Covington
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.